FDA approved the Genio system for OSA treatment on August 9, 2025.

4 reports, 1 independent Updated Sep 10

Gone quiet

Reports: 4
Developments: 1
Repetition: 75%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

FDA approved the Genio system for OSA treatment on August 9, 2025.

Who's involved

What this event is mainly about

FDA

Keep exploring

Part of

FDA approved the Genio system for the U.S. market on August 19, 2025, following company reports from Mont-Saint-Guibert and the start of commercial launch. All 2 developments

The entities involved

FDA
- Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
- A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56

Coverage

Newest first; wire copies grouped

Aug 9GlobeNewswireNyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea INSIDE INFORMATION REGULATED INFORMATION Nyxoah Receives Approval from FDA for Genio® System for the T

3 more outlets ran the same wire story